Drugs / Magnesium group
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07528612 | Apr 2026 → Dec 2027 expected | — | Region Halland | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Magnesium group | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07528612 ↗ |
| Known as | magnesium | “The study aims to investigate whether a commonly used medicine, magnesium, can help reduce pain after a Caesarean section.” NCT07528612 ↗ |
| Route | Intravenous | “giving magnesium intravenously during planned Caesarean sections” NCT07528612 ↗ |